Peregrine Bounced Back (PPHM, LPR, GNK, INXN, GHDX)

NEW YORK, September 19, 2012 (MESHPRESS) – Earlybirdtrades.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-

Peregrine Pharmaceuticals(NASDAQ PHM) shares jumped 5.25% and closed at $4.41 in the last trading session. The company announced that its management team will be meeting with investors to review its portfolio of novel drug candidates and the recent positive clinical data from the company’s Phase II trial in second-line non-small cell lung cancer, as part of the 3rd Annual Credit Suisse 2012 Small & Mid Cap Conference. The event will be held at The New York Palace Hotel in New York, New York, with management conducting meetings on Friday, September 21, 2012. Additionally, equities research analysts at Roth Capital increased their price target on shares of Peregrine Pharmaceuticals from $5.00 to $9.00 in a research note issued to investors on Sept. 10.

Can PPHM Hit New Highs After The recent Momentum? Find Out Here

Lone Pine Resources Inc(NYSE:LPR) shares climbed 4.90% and closed at $1.50 in the previous trading session after Equities researchers at Scotia Capital dropped their target price on shares of Lone Pine Resources from $4.00 to $3.00 in a report issued yesterdy. The firm currently has a “sector perform” rating on the stock.

Additionally, the company announces that it has engaged RBC Capital Markets to assist the Company in completing a review of the Company’s asset portfolio to identify and evaluate potential transaction alternatives to deleverage the Company’s balance sheet, improve liquidity, and position the Company to increase the value of its concentrated portfolio of high quality assets.

Can LPR Extends Gain? Find Out Here

Genco Shipping & Trading Limited(NYSE:GNK) shares increased 4.59% and closed at $4.10 in yesterday’s session. The 52 week trading range for the company is $2.09 – $10.14. The shares of the company plunged 47% in the last one year. The company is engaged in the ocean transportation of drybulk cargoes worldwide through the ownership and operation of drybulk carrier vessels.

How Should Investors Trade GNK Now? Find Out Here

InterXion Holding NV (NYSE:INXN) shares jumped 4.44% and closed at $21.41 in the last trading session. The company as announced its collaboration with TMX Atrium to deliver unrivalled Canadian market data feeds to their respective financial services communities.

Additionally, Benchmark Co. raised its price target on shares of InterXion Holding from $22.00 to $25.00. They have a buy rating on the stock.

Can INXN Extend Gain? Find Out Here

Genomic Health, Inc.(NASDAQ:GHDX) shares climbed 4.95% and closed at $35.40 in the previous trading session. The company announced positive results from a large clinical validation study of its biopsy-based prostate cancer test.

The company stated that the study, performed in collaboration with leading prostate cancer researchers at the University of California, San Francisco or UCSF, met its primary endpoint by demonstrating that the multi-gene Oncotype DX Genomic Prostate Score or GPS, assessed in prostate needle biopsy tumor tissue, has been prospectively validated as a predictor of adverse pathology for patients with early-stage prostate cancer.

Can GHDX Bounce Back Further? Find Out Here

About Early Bird Trades

Early Bird Trades has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer:

The assembled information disseminated by earlybirdtrades.comis for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. earlybirdtrades.comdoes expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.